Levofloxacin Injection, Solution
Product Images NDC 0409-3330

6 FDA label images from Hospira, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0409-3330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lev20 0001 01)

Figure 1 (Lev20 0001 01)
Chemical structure diagram of levofloxacin, showing its molecular framework including key functional groups and bonds.*
FDA Label Image

Figure 2 (Lev20 0001 02)

Figure 2 (Lev20 0001 02)
A line graph showing drug concentration over time after intravenous administration of Levofloxacin injection solution at two different strengths, 750 mg/150 mL and 750 mg/100 mL. The x-axis represents time in hours, and the y-axis represents drug concentration with corresponding error bars.*
FDA Label Image

Figure 3 (Lev20 0001 03)

Figure 3 (Lev20 0001 03)
A line chart depicting the percentage of levofloxacin remaining in plasma over time following administration of 500 mg oral tablets and 500 mg intravenous doses. The x-axis represents time in hours, and the y-axis represents the percentage of the dose remaining in plasma, illustrating pharmacokinetic profiles for both dosing methods.*
FDA Label Image

Principal Display Panel – 250 mg/50 mL Carton Label (Lev20 0001 04)

Principal Display Panel – 250 mg/50 mL Carton Label (Lev20 0001 04)
Levofloxacin 250 mg/50 mL (5 mg/mL) injection in 5% Dextrose Injection carton label for intravenous use. The label indicates infusion over 60 minutes and contains 24 bags of 50 mL each. Manufactured by Hospira, Inc, the packaging shows the proprietary and generic name, dosage strength, infusion instructions, and storage directions, with the Hospira logo prominently displayed.*
FDA Label Image

Principal Display Panel – 500 mg/100 mL Carton Label (Lev20 0001 05)

Principal Display Panel – 500 mg/100 mL Carton Label (Lev20 0001 05)
Packaging label for Levofloxacin 500 mg/100 mL (5 mg/mL) injection, solution in 5% Dextrose, for intravenous use. The label specifies infusion over 60 minutes and advises to leave the bag in the overwrap until use. The package contains 24 x 100 mL bags. The labeler is Hospira, Inc. NDC 0409-3330-24 is displayed.*
FDA Label Image

Principal Display Panel – 750 mg/150 mL Carton Label (Lev20 0001 06)

Principal Display Panel – 750 mg/150 mL Carton Label (Lev20 0001 06)
Packaging label for Levofloxacin 750 mg/150 mL (5 mg/mL) injection in 5% Dextrose Injection. The product is supplied in 24 bags of 150 mL each, labeled for intravenous use with directions to infuse over 90 minutes. The labeler is Hospira, Inc. The packaging includes instructions to leave the bag in the overwrap until use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.